Multiple Manufacturers

CYTARABINE

Manufacturer:

Multiple Manufacturers

Cytarabine HCPCS:

J9100

HCPCS Code Descriptor:

Injection, cytarabine, 100 mg

Category:

J Code

Cytarabine NDCs:

61703-0304-36, 71288-0109-20, 25021-0223-20, 67457-0454-50, 67457-0452-20, 61703-0319-22, 63323-0120-20, 61703-0305-38, 61703-0303-46, 25021-0229-05, 67457-0455-52

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

67457-0454-50, 67457-0452-20, 61703-0305-38, 25021-0229-05, 67457-0455-52

About Cytarabine:

CYTARABINE is a medication manufactured by multiple manufacturers and aligned to the J Code: J9100. CYTARABINE is administered via the injection route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9100 Added Date:

January 1, 1986

J9100 Effective Date:

January 1, 2009

J9100 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cytarabine billing and coding information.
Cytarabine patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
Our team is still working to identify a prescribing information source for CYTARABINE
Our team has not yet identified a source of side effects information for CYTARABINE. Please check back in a few weeks.